%0 Generic
%T Phase II study to evaluate efficacy and safety of irinotecan, capecitabine, and bevacizumab in patients with metastatic colorectal cancer (mCRC).
%A Garcia Alfonso, P.
%A Chaves, M.
%A Muñoz Martin, A.
%A Salud Salvia, A.
%A Vilchez, R.
%A Yuste, A.
%A Gravalos Castro, C.
%A Queralt Merino, B.
%A Gonzalez Flores, E.
%A Lopez Ladron, A.
%A Losa, F.
%A Oltra Ferrando, A.
%A Gomez Reina, M. J.
%A Campos, J. M.
%A Aranda, E.
%I American Society of Clinical Oncology (ASCO)
%@ 1527-7755
%@ 0732-183X
%K Cancer Research
%K Oncology
%D 2011
%C American Society of Clinical Oncology (ASCO)
%U http://slubdd.de/katalog?TN_libero_mab2
Download citation